ActivistActivist / 5%+ stake disclosed (SCHEDULE 13D/A)
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- Nasdaq
- State of incorporation
- DE
- Form
- SCHEDULE 13D/A
- Filed
- June 3, 2025
Filings & documents
Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.
Source filing ↗SCHEDULE 13D/A · the filing we parseAll documents in this filing ↗accession 0001415889-25-015487Taysha Gene Therapies, Inc. — all SEC filings ↗EDGAR company pageManning Paul B — 8-K announcements ↗where the spin-off was announcedManning Paul B — all SEC filings ↗parent EDGAR company page